Proanthocyanidin Polymer Compositions for Industrial Fluid Flow Regulation
Legal Citation
Summary of the Inventive Concept
The inventive concept leverages the core technology of proanthocyanidin polymer compositions to regulate fluid flow in various industrial processes, enabling improved efficiency, reduced waste, and increased productivity.
Background and Problem Solved
The original patent disclosed the use of proanthocyanidin polymer compositions for treating congenital diarrhea disorder. However, the limitations of this approach were confined to medical applications. The new inventive concept addresses the need for effective fluid flow regulation in industrial processes, where current solutions often result in excessive water loss, reduced efficiency, and environmental concerns.
Detailed Description of the Inventive Concept
The inventive concept comprises a proanthocyanidin polymer composition effective to regulate fluid secretion in various industrial processes. The composition can be administered to fluid flow systems, agricultural irrigation systems, industrial processes, oil wells, and cooling systems to reduce fluid loss, improve efficiency, and minimize environmental impact. The proanthocyanidin polymer composition inhibits fluid secretion, reducing water loss and improving waste treatment efficiency.
Novelty and Inventive Step
The new claims introduce a novel application of proanthocyanidin polymer compositions to industrial fluid flow regulation, which is non-obvious and unanticipated from the original patent's medical focus. The inventive concept's novelty lies in the recognition of the polymer's potential to regulate fluid flow in diverse industrial contexts.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include variations in the composition's formulation, delivery methods, and system integration. For example, the proanthocyanidin polymer composition could be incorporated into membranes, coatings, or additives for industrial processes. Additionally, the composition could be tailored for specific industrial applications, such as oil recovery or wastewater treatment.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including agriculture, oil and gas, manufacturing, and energy production. The market for industrial fluid flow regulation is substantial, with opportunities for cost savings, increased efficiency, and environmental benefits. The inventive concept could be licensed to companies operating in these industries or developed into proprietary products and services.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/353 |
| A | A61 | A61K9/0095 |
| A | A61 | A61K9/28 |
| A | A61 | A61K9/48 |
| A | A61 | A61P1/04 |
| A | A61 | A61P1/12 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Polymer chemistry, pharmaceutical sciences, and industrial fluid management with expertise in molecular composition modification and fluid regulation techniques
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degree in chemistry or chemical engineering, understanding polymer interactions, fluid dynamics, and cross-disciplinary applications of molecular compounds
Obviousness Rationale
A skilled practitioner would recognize the fundamental fluid-regulating properties of proanthocyanidin polymers disclosed in the medical patent and naturally extend those molecular interaction principles to industrial fluid management contexts. The core mechanism of fluid secretion inhibition demonstrated in medical applications provides a clear technical foundation for exploring similar regulatory effects in non-medical systems. The polymer's inherent chemical structure suggests transferable properties across different fluid interaction scenarios.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,510 |
|---|---|
| Title | Methods and compositions for treating congenital diarrhea disorder |
| Assignee(s) | NAPO PHARMACEUTICALS, INC. |